Why the study?
Does elevated BMI improve survival or reduce morbidity in individuals suffering from chronic diseases?
Does elevated BMI improve survival or reduce morbidity in individuals suffering from chronic diseases?
This review highlights the obesity paradox, suggesting that being overweight or obese may be protective in chronic diseases and questioning the validity of standard BMI categories for these patients.
Answers are grounded in this paper and cite their sources.
Obesity paradox may warrant caution against routine weight loss in chronic disease; leaves open need for prospective trials.
Obesity is a complex condition classically characterised by excessive body fat accumulation and represents one of the most important public health problems worldwide. Although several epidemiological studies have shown that elevated BMI is associated with higher morbidity, and with increased rate of death from all causes and from cardiovascular disease, accumulating evidence suggests that being overweight or obese may be protective (the so-called obesity paradox), at least in chronic diseases. These observations, not only question the validity of the BMI system, but also raise the intriguing question of whether we should redefine what the normal range of BMI is in individuals suffering from a chronic disease. In the present article, we review the available information on the association between elevated BMI and increased morbidity and mortality including obesity-related paradoxes, explore key aspects of the role and limitations of BMI as a measure of increased adiposity and outline potential solutions to address the current controversies regarding the impact of obesity on human health.
No takes yet. Share an insight, caveat, or question.
Egom et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: